In the article “Common Estrogen Receptor Polymorphism Augments Effects of Hormone Replacement Therapy on E-Selectin but Not C-Reactive Protein” by Herrington et al, which appeared in the April 23, 2002, issue of the journal (Circulation. 2002;105:1879–1882), and the editorial, “Hormone Replacement Therapy and Heart Disease: Replacing Dogma With Data” by David M. Herrington, MD, MHS, which appeared in the January 7/14, 2003, issue of the journal (Circulation. 2003;107:2–4), a citation was erroneously inserted giving the impression that the Estrogen in the Prevention of Atherosclerosis Trial (EPAT) found no evidence of benefit of hormone replacement therapy on atherosclerosis in women with established cardiovascular disease.
The correct citation in both articles should have been:
Schulman SP, Thiemann DR, Ouyang P, et al. Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina. J Am Coll Cardiol. 2002;39:231–237.